Stigma, years-long diagnostic delays, and limited follow-up after a crisis remain hurdles for people with serious mental illness, experts say.
|Articles|July 1, 2001
Supplements and Featured Publications
- Improving the Treatment of Epilepsy in the Era of Managed Care
- Volume 7
- Issue 7 Suppl
Pharmacokinetics of the New Antiepileptic Drugs
Author(s)Barry E. Gidal, PharmD
Advertisement
Articles in this issue
over 25 years ago
Participating Facultyover 25 years ago
Introductionover 25 years ago
Evaluation of the Patient with Epilepsyover 25 years ago
The Role of New Antiepileptic Drugsover 25 years ago
Treatment of Epilepsy in Three Specialized Populationsover 25 years ago
Roundtable Discussionover 25 years ago
Continuing Medical Education Quizover 25 years ago
Selected AbstractsAdvertisement
Related to this article
MedHaul’s platform streamlines nonemergency medical transportation, boosting on-time oncology visits, reducing costs, and helping patients reach critical care across underserved regions.
A 39,669-patient French cohort found ustekinumab and IL-23 inhibitors carry the lowest infection risk among biologics.
CMS' rule ending Medicaid and CHIP funding for pediatric sex-rejecting procedures is now in effect.
At a roundtable in Cleveland, kidney experts said IgA nephropathy and FSGS often go unrecognized, calling for EHR flags and better referral channels.
Labial gland biopsy may support diagnosis of neurologic Sjögren disease, especially when antibody tests are negative or inconclusive.
This analysis in RR MCL shows CAR T-cell therapy (brexucabtagene) yields higher complete responses vs bispecific antibodies; durability remains unclear.
Meta-analysis finds oral JAK inhibitors like baricitinib and ritlecitinib drive strong alopecia areata hair regrowth, improving SALT scores with manageable safety.
Advertisement
Advertisement
Trending on AJMC
1
Oral JAK Inhibitors Boost Hair Regrowth Odds in Alopecia Areata
2
CMS Rule Ends Medicaid, CHIP Funding for Pediatric Gender Care
3
Medicare Drug Price Negotiations Yield Uneven Out-of-Pocket Savings
4
Follitropin Delta Achieves Ongoing Pregnancy in 64% Under Age 35
5